Traders Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Knott David M Jr lessened its position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 32.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 40,000 shares of the biopharmaceutical company’s stock after selling 19,500 shares during the quarter. Knott David M […]
StockNews.com began coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently issued reports on XENE. Wedbush reiterated an outperform rating and set a $47.00 price objective […]
Moran Wealth Management LLC purchased a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 67,613 shares of the biopharmaceutical company’s stock, valued at approximately $2,420,000. Moran Wealth Management LLC owned about 0.11% of Xenon […]
Victory Capital Management Inc. acquired a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 28,190 shares of the biopharmaceutical company’s stock, valued at approximately $1,009,000. Several other large investors also recently modified their holdings of XENE. […]